Aberdeen Wealth Management LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1802654
LAKE BLUFF, IL
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,530
-$253,817 QoQ
Shares Held
65
-76.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,110
of 1,297 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aberdeen Wealth Management LLC holds $380,485 across 6 Biotechnology names. REGN ranks #4 (10.7% of the industry book) .
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,530 | 65 | Shares | Sole | 2026-08-13 | |
| 2024-09-30 | $294,347 | 280 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $304,798 | 290 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $288,747 | 300 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $263,487 | 300 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $246,888 | 300 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $215,562 | 300 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $246,501 | 300 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $252,521 | 350 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $241,104 | 350 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $206,895 | 350 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $244,447 | 350 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $221,032 | 350 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $226,942 | 375 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $209,452 | 375 | Shares | Sole | 2021-07-23 | |
| 2020-06-30 | $225,137 | 361 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $217,289 | 445 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||